CBD oxidation product HU-331 is a potential anticancer therapeutic

One recent study reviewed the literature related to the anticancer activity of HU-331, a CBD oxidation product, in purified systems, cancer cell lines, and animal models. The study concluded that HU-331 displays anticancer activity without some of the known adverse events associated with traditional anticancer agents.

Read more here: https://link-springer-com.login.ezproxy.library.ualberta.ca/article/10.1186/s42238-021-00067-z